Precision-engineered supporting technology designed for genomic laboratory pipelines, offering environment-stabilized analysis platforms, carrier gas supply, automation interfaces, and automated extraction instrumentation.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Our infrastructure enables high-throughput assembly of diagnostic instrumentation with rigorous quality inspections spanning optoelectronic calibration, microfluidic integrity tests, and environmental simulation profiles.
Next-Generation Sequencing (NGS) is transitioning rapidly from research institutes to bedside clinical diagnostic ecosystems. Our R&D team addresses key technical bottlenecks in the library preparation and optical capture workflow.
Achieving high signal-to-noise ratios in flow cell imaging requires precision sub-micron alignment. Our platform developments minimize spatial aberration, optimizing base-calling accuracy on high-density sequencing chips.
Automating magnetic bead cleanup, enzymatic fragmentation, and adapter ligation reduces human variable error. Integrated microfluidics allow walkaway performance for multiple library samples in clinical settings.
Future-proofing NGS platforms involves simultaneous processing of genomic, transcriptomic, and epigenetic markers. Advanced thermal cyclers and solid-state sensors align with this integrated workflow.
BioX Medical designs medical-grade hardware ecosystems to address practical throughput, automation, and clinical diagnostic requirements across various industry verticals:
Targeted gene panels for somatic mutation profiling require stable laboratory platforms. Integrating ultra-pure DI water filtration systems and high-precision anti-vibration tables ensures noise-free optical signals, improving the detection limits for circulating tumor DNA (ctDNA).
Outbreak monitoring demands rapid, field-deployable extraction and PCR confirmation. Our multi-channel real-time PCR systems support dynamic target detection, allowing public health agencies to track viral variations, bacterial pathogens, and zoonotic vectors.
High-volume seed-batch validation requires cost-efficient, high-throughput extraction instruments. Using specialized inert gas systems, such as compact nitrogen generators, protects reactions from humidity and oxidation during high-throughput analysis.
Operating from Shenzhen—the global epicenter of advanced medical electronics—allows BioX Medical to source high-grade components with minimal turnaround times. From custom optical lenses to precise CNC mechanical brackets, our supply chain is optimized for resilience and cost control.
Our Factory 4.0 architecture integrates ERP systems with automated QA platforms. Every real-time PCR channel, fluidic pump, and automatic nucleic acid extractor is tracked through a serialized database, logging optical calibrations, thermal cycle stability, and vacuum seal profiles to ensure performance traceability.
A visual representation of our manufacturing processes, including cleanroom systems, calibration zones, and optical inspection equipment at our Shenzhen factory.
Distributing molecular diagnostic instruments globally requires compliance with regional regulatory standards. BioX Medical ensures all clinical instruments and reagents are developed under strict quality management structures.
Our facility operates under the ISO 13485 quality management system for medical devices, guaranteeing traceability from raw materials to final shipping.
Selected diagnostic systems and rapid tests hold CE-IVD status, allowing easy import and regulatory clearing for European and associated medical markets.
Robust physical design, secure transit packaging, and compliance with LVD and EMC testing protect electronic diagnostic systems during distribution.
We provide end-to-end customization services for global diagnostic distributors, pharmaceutical brands, and lab network buyers:
To safeguard international supply agreements, we maintain rolling raw-material reserves for key microprocessors, linear rails, optical sensors, and thermal cyclers. This structure protects our partners from sudden market shifts, securing reliable lead times and predictable shipping schedules.
Every shipment includes complete quality inspection certificates, functional test printouts, and custom packaging designed to protect fragile optics and electronics during long-distance transportation.
Discover our high-capacity molecular diagnostics line, pathogen analytical systems, laboratory sterile barrier modules, and precision engineering systems.
Common questions regarding molecular hardware customization, sourcing, alignment requirements, and operational integration.
High-throughput molecular analyzers utilize advanced laser illumination systems and high-density CCD/CMOS sensors to detect fluorescent responses on micrometric coordinates. Even micro-vibrations from internal pumps, cooling fans, or external facility traffic can cause signal overlap and base-calling errors. Employing a high-precision, benchtop anti-vibration platform isolates the optical assembly from these micro-vibrations, maintaining signal integrity and data accuracy.
Nitrogen acts as a clean, dry, and inert purge gas that protects sensitive biological reagents and samples from oxidation and ambient humidity. In high-throughput testing systems, gas purging is used to dry sample wells or maintain inert atmospheres in flow lines. A local compact nitrogen generator provides a continuous, high-purity supply of nitrogen, eliminating the logistics and contamination risks of high-pressure gas cylinders.
Automated magnetic-bead-based extraction systems, like the Biobase Extractor or My-B020ia-1, standardize lysis, washing, and elution phases. Automated handling reduces cross-contamination, eliminates technician pipetting errors, and ensures consistent yield and purity of extracted DNA/RNA. This consistency is essential for high-sensitivity applications like NGS and digital PCR.
All design and assembly stages follow ISO 13485 quality standards. Instruments and assays are certified to CE-IVD standards where applicable, with extensive electromagnetic compatibility (EMC) and low-voltage electrical safety testing. Our validation documentation includes Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) support protocols, assisting international clients through domestic registration and regulatory pathways.
Our diagnostic hardware customizations cover physical housing colors and logos, firmware integrations, custom wavelength optical filter configurations (supporting specific reporter dyes), fluidic flow adjustments, and specialized software layouts. We also support custom reagent validation, tailoring extraction profiles and thermal cycle patterns to match your target assay designs.
BioX Medical
